Accelerated atherosclerosis in dialysis patients is characterized by severe vascular
calcification, and the magnitude of vascular calcification is associated with increased …

Abstract Aim Fetuin‐A (F et‐A) is an important regulator of extracellular matrix
mineralization. F et‐A plays a critical role in the formation and stabilization of high molecular …

Background and objectives: Vascular calcification and endothelial dysfunction contribute to
the development of cardiovascular disease in patients with chronic kidney disease (CKD) …

Background. Fetuin-A, also called Alpha 2-Heremans Schmid Glycoprotein, is a
multifunctional plasma agent what has been proven in animal and human studies. It plays a …

Background—Fetuin-A, a protein almost exclusively secreted by the liver, induces insulin
resistance and subclinical inflammation in rodents. Circulating fetuin-A levels are elevated in …

Fetuin was first isolated from bovine serum in 1944. It is now most commonly known as
either fetuin-A or alpha-2-HS-glycoprotein (AHSG), the protein product of Ahsg gene. A …

Background—Elevated circulating levels of fetuin-A in blood have been associated with
increased risk of cardiovascular disease. The goal of our study was to prospectively …

Aims Fetuin-A has been identified as a potent circulating inhibitor of ectopic calcification. We
investigated the relationship between baseline fetuin-A serum levels and the rate of …

Both vascular calcification and inflammation are common in patients with chronic kidney
disease (CKD). In patients on dialysis, there is increased coronary artery and peripheral …

Objective Alpha2-Heremans Schmid glycoprotein/Fetuin-A (AHSG) is a circulating negative
acute-phase protein, which inhibits bimineralization. It is often considered as a potential …